Apheresis Market by Product (Devices and Disposables), Technology (Centrifugation and Membrane Separation), Procedure (Therapeutic Apheresis (Therapeutic Apheresis Disposables (Blood Disorders, Autoimmune Disorders, Metabolic Disorders, and Neurological Disorders), Therapeutic Apheresis Devices, and Automated Blood Collection)), Application (Photopheresis, Leukapheresis, Plasmapheresis, and Plateletpheresis) and End User (Hospitals and Blood Centers) - Global Analysis & Forecast 2020-2030

Report ID : 332  |  Published Date : Jul 2020  |  Pages : 180  |  Region : Global  |  Report Code : MD-103

Apheresis Market Overview and Introduction

Apheresis is a medical procedure that involves removing blood from a donor. The whole blood then goes through a separating procedure wherein it is separated into individual components so that one particular component can be removed. The remaining blood components are then re-introduced back into the bloodstream of the donor. In the apheresis procedure, blood is removed from the body through an intravenous line and enters the machine where the components are separated. Apheresis is often done on donors where blood is centrifuged to obtain individual components, for instance, RBCs, platelets, plasma, and others, for transfusion in different patients.

The global apheresis market is majorly driven by the upsurge in blood component demands owing to the rising prevalence of chronic diseases and the growing number of trauma & injury cases globally. According to the WHO, the burden of chronic diseases is expected to increase to 57% by 2020. Almost half of the total deaths are caused by chronic ailments such as cardiovascular diseases, obesity, and diabetes. Also, apheresis is widely used as a therapy for various diseases such as thrombotic thrombocytopenic purpura, hemolytic uremic syndrome, drug toxicities, autoimmune disease, sepsis, and fulminant hepatic failure. Promising reimbursement policies for apheresis procedures are leading to the increased number of patients opting for such procedures. Furthermore, a rise in the number of complex surgical procedures is also leading to an increased demand for apheresis procedures. These factors are anticipated to propel market growth during the forecast period. However, the high cost of apheresis devices & therapeutic apheresis procedures may hinder market growth to a certain extent.

The global apheresis market has been segmented into the following categories - product, technology, procedure, application, and end user.

Apheresis Market By Product

Based on product, the market can be segmented into devices and disposables. The devices segment will dominate the market during the forecast period owing to an increase in the number of blood centers, increasing device installations in hospitals for therapeutic apheresis treatments coupled and the rapidly growing demand for apheresis procedures.

Apheresis Market By Technology

Based on technology, the market can be segmented into centrifugation and membrane separation. The centrifugation segment accounted for the largest market share owing to advantages offered by centrifugation such as the high efficiency of centrifugation and the ability to separate different types of blood components, which are propelling growth of the centrifugation technology segment.

Apheresis Market By Procedure

Based on procedure, the market can be segmented into therapeutic apheresis and automated blood collection. Therapeutic apheresis is further segmented into therapeutic apheresis disposables and therapeutic apheresis devices. Therapeutic apheresis disposables are further segmented into blood disorders, autoimmune disorders, metabolic disorders, neurological disorders, and others. The therapeutic apheresis segment dominated the market owing to the increasing adoption of apheresis in therapeutically to treat various disorders.

Apheresis Market By Application

Based on application, the market can be segmented into photopheresis, leukapheresis, plasmapheresis, plateletpheresis, and others. The plasmapheresis segment dominated the market owing to the increasing prevalence of blood disorders, favorable reimbursement policies for apheresis procedures and the rising demand for photopheresis in organ transplant rejection treatments.

Apheresis Market By End User

Based on end user, the market can be segmented into hospitals, blood centers, and others. The blood centers segment dominated the market due to the increasing number of blood collection centers as well as the rising awareness regarding blood collection.

Apheresis Market By Region

Based on the region, the global Apheresis market can be segmented into North America, Europe, Asia Pacific, and the Rest of the World (ROW).  North America dominated the market owing to the rising prevalence of chronic diseases owing to lifestyle disorders along with a strong presence of leading market players, resulting in advanced blood collection technologies. Moreover, a well-established healthcare infrastructure will further contribute to the overall market growth in this region.

Apheresis Market Prominent Players

Some of the key players operating in the global apheresis market include TERUMO BCT, INC., Fresenius SE & Co. KGaA, Haemonetics Corporation, Baxter., Asahi Kasei Medical Co., Ltd., B. Braun Melsungen AG, Cerus Corporation., KANEKA CORPORATION, KAWASUMI LABORATORIES. INC., Nikkiso Co., Ltd, and others.